ARYx Therapeutics, Inc.
OTC: ARYX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Paul Goddard
- Employees
- 56
- Headquarters
- Fremont, United States
- IPO year
- 2007
- Market cap
- $16.7K
- Website
- https://www.aryx.com
Loading ARYX…
Loading profile data…Frequently asked questions about ARYX
What does ARYx Therapeutics, Inc. (ARYX) do?
Based in Fremont, California, and established in 1997, ARYx Therapeutics, Inc. is dedicated to discovering and advancing innovative treatments, primarily focusing on widespread, chronic conditions addressable with oral medications. The company utilizes its unique RetroMetabolic Drug Design technology to engineer distinctive molecular compounds t...
Where does ARYX trade?
ARYx Therapeutics, Inc. (ARYX) trades on the Other OTC.
What sector is ARYX in?
ARYx Therapeutics, Inc. (ARYX) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of ARYx Therapeutics, Inc.?
Paul Goddard is the chief executive officer of ARYx Therapeutics, Inc. (ARYX).
Where is ARYx Therapeutics, Inc. headquartered?
ARYx Therapeutics, Inc. is headquartered in United States.
Does ARYX pay a dividend?
ARYx Therapeutics, Inc. (ARYX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ARYX go public?
ARYx Therapeutics, Inc. (ARYX) completed its initial public offering in 2007.